Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sikun Meng

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Medicine|June 21, 2026
Identification of Novel Small-Molecule Inhibitors Targeting KDM5B and Evaluation of Their Antitumour EffectsTomoaki Hara, Sikun Meng, Masamitsu Konno, et al.
International Journal of Oncology|June 7, 2024
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionalityHiromichi Sato, Sikun Meng, Kazuki Sasaki, et al.
Cancer Science|April 25, 2024
High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer markerTomoaki Hara, Sikun Meng, Hiromichi Sato, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Medicine|June 21, 2026
Identification of Novel Small-Molecule Inhibitors Targeting KDM5B and Evaluation of Their Antitumour EffectsTomoaki Hara, Sikun Meng, Masamitsu Konno, et al.
International Journal of Oncology|June 7, 2024
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionalityHiromichi Sato, Sikun Meng, Kazuki Sasaki, et al.
Cancer Science|April 25, 2024
High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer markerTomoaki Hara, Sikun Meng, Hiromichi Sato, et al.
Pageof 3